Ticker / mid cap

TGTX

TG Therapeutics, Inc.
1
Contracts
$133.5M
Total Value

Stock Metrics

21.7%
Short % Float
13.6d to cover · High squeeze
69.7%
Inst % Float
10 holders · 2026-06-30
Blackrock Inc.
Top Holder
14.4% of float
135.1M sh
Public Float
11/100
Dilution Score
Low
54 mo
Cash Runway
Verified regulatory filings & proprietary analysis.

Fleet Intelligence

Dilution Risk
11/100
LOW
Inst: 69.65% · Top: Blackrock Inc.
Squeeze risk: HIGH

Contracts

DateSourceTitleAwardeeValueScore
2023-09-26usaspending75A50323F80027PARTNER THERAPEUTICS, INC$133.5M0.3

News Signals

TG Therapeutics, Inc. (TGTX) Q2 2026 Earnings Call Transcriptseeking_alpha 16d
TGTX — Material Event (8-K)edgar 17d
TGTX — Material Event (8-K)edgar 69d